
NeurologyLive® Friday 5 — June 19, 2026
Key Takeaways
- Neurofilament light chain is emerging as a peripheral neuropathy biomarker, but interpretation is constrained by disease heterogeneity, assay standardization, and unclear thresholds for individual-level clinical decision-making.
- Positioning sleep as a core health behavior can improve pediatric neurologic outcomes, requiring family-centered counseling, routine screening for sleep problems, and integration with comorbidity management.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 19, 2026.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Click the read more or watch now buttons for more details and information about each highlight.
1: The Promise and Limitations of Neurofilament Light Chain in Peripheral Nerve Disorders: Brett Morrison, MD, PhD
In a recent interview at the 2026 PNS Annual Meeting, Brett Morrison, MD, PhD, associate professor at Johns Hopkins University, discussed the current landscape of biomarkers in peripheral nerve disorders and the evolving role of neurofilament light chain in clinical care and research. [WATCH TIME: 3 minutes]
2: Advocating for Sleep as a Foundational Health Behavior in Clinical Practice: Beth Malow, MD, MS
In a recent interview at SLEEP 2026, Beth Malow, MD, MS, professor of neurology and pediatrics at Vanderbilt University Medical Center, discussed her advocacy for sleep health, especially for pediatric patients and their families. [WATCH TIME: 5 minutes]
3: Irfan Qureshi, MD, on Opakalim, Kv7 Activation, and the Future of Epilepsy Treatment
In a recent Q&A, Irfan Qureshi, MD, chief medical officer at Biohaven, discusses newly reported data on opakalim, highlighting durable seizure control, favorable CNS tolerability, and the investigational agent’s potential role across multiple epilepsy syndromes.
4: Applying the New Evidence-Based Guidelines to Screen for Sleep Apnea in Hospitalized Patients: Sunil Sharma, MD
In a recent interview at SLEEP 2026, Sunil Sharma, MD, section chief in the Division of Pulmonary Critical Care and Sleep Medicine at West Virginia University, discussed the high burden of undiagnosed sleep apnea in hospitalized patients. [WATCH TIME: 5 minutes]
5: Noninvasive Spinal Cord Stimulation Plus Therapy Shows Promise for Improving Function in MS
In a recent Q&A, neurologists Sarah Simmons, MD, PhD, and Fatma Inanici, MD, PhD, discuss how the combination of noninvasive cervical spinal cord stimulation with exercise therapy can improve upper extremity function in people with multiple sclerosis.
Which conversation stood out most to you in this week’s NeurologyLive Friday Five?
Don’t have time to read or watch a full video interview?











